- Home
- CSPI vs COYA Comparison
CSPI vs COYA Comparison
Compare CSPI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSPI | COYA |
|---|---|---|
| Founded | 1968 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.8M | 126.6M |
| IPO Year | 1987 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CSPI | COYA |
|---|---|---|
| Price | $11.27 | $4.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 16.1K | ★ 323.0K |
| Earning Date | 02-09-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $58,730,000.00 | $3,987,706.00 |
| Revenue This Year | N/A | $70.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $9.65 | $3.94 |
| 52 Week High | $21.95 | $8.29 |
Technical Indicators
Market Signals| Indicator | CSPI | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 41.72 |
| Support Level | $11.28 | $4.01 |
| Resistance Level | $12.94 | $4.95 |
| Average True Range (ATR) | 0.60 | 0.40 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 24.17 | 40.35 |
Price Performance
Historical ComparisonAbout CSPI CSP Inc.
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.